Clariant and Eta Bio announce license agreement on sunliquid® cellulosic ethanol technology in Bulgaria


CLA Eta Bio Press photo
  • The agreement marks the fourth signed license deal for Clariant’s sunliquid® technology
  • Eta Bio Ltd., was established by the Pavlovi family, that manages one of the largest agricultural businesses in Bulgaria, in order to extend their business into renewable energy
  • The company intends to realize a full-scale commercial plant for the production of cellulosic ethanol at a site in Northeast Bulgaria with Clariant’s sunliquid® technology
  • License deal represents another milestone toward the commercialization of sunliquid® technology for advanced biofuels in Europe

Muttenz, July 27, 2020 – Clariant, a focused, sustainable and innovative specialty chemical company, and Eta Bio, a company of the Pavlovi family, running a leading business in the agricultural sector in Bulgaria, today announced that a license agreement for the sunliquid® cellulosic ethanol technology has been signed.

Eta Bio has been recently established with the purpose to construct, own and operate a full-scale commercial plant for the production of cellulosic ethanol from agricultural residues. For Clariant, the announcement of its fourth license agreement keeps the momentum for its innovative and sustainable sunliquid® technology going and represents another significant step towards its commercialization.

“Our sunliquid® technology is trendsetting for the development of sustainable and advanced biofuels. The continued success strongly demonstrates that our technology meets the market needs for sustainable solutions and gives us a competitive edge”, said Hans Bohnen, Clariant’s Chief Operating Officer.

“After signing license agreements with first-generation ethanol producers, as well as mineral oil players, we are excited to also gain a foothold in another important customer segment – the agricultural sector – with our sunliquid® technology”, adds Christian Librera, Clariant’s Head of Business Line Biofuels and Derivatives.

Eta Bio will perform the project development and plant operation at a greenfield site in General Toshevo, the Northeastern region of Bulgaria, utilizing available land, owned by the Pavlovi family, and existing infrastructure. The annual production capacity is planned to be 50,000 tons of cellulosic ethanol, processing around 250,000 tons of wheat straw, which is an abundant resource in the region, also known as the granary of Bulgaria.

“The realization of the first Bulgarian cellulosic ethanol production project will help to solve one of the main challenges agricultural producers face in the region – the removal of the straw from the fields. This project will give us the chance to have an additional revenue stream from agricultural leftovers”, emphasized Kiril Pavlov, Managing Director of Eta Bio. 

By using locally sourced feedstock, greenhouse gas savings can be maximized and additional business opportunities along the entire value chain will arise.

“We are excited to enter the renewable energy sector with this project and hence become a pioneer in the advanced biofuels market in Bulgaria. This undertaking will allow us to further diversify our business portfolio, as well as strengthening our position in the agricultural sector”, highlighted Hristo Pavlov, who co-manages the agricultural business of the group.

For Bulgaria, this constitutes an essential investment in green, sustainable technologies. The produced cellulosic ethanol will be used as a gasoline additive to fulfill the country’s blending mandate for advanced biofuels, as laid out in the Renewable Energy Directive (RED) II.

The project is comprised of a license of a sunliquid® basic engineering package, the provision of technical services, as well as the supply of starter cultures from Clariant’s proprietary enzyme and yeast platform to process Eta Bio’s feedstock into cellulosic ethanol.
 

Aviso legal:
Estas informações correspondem ao estado atual do nosso conhecimento, destinando-se à descrição geral de nossos produtos e suas possíveis aplicações. A Clariant não fornece nenhuma garantia, implícita ou explícita, quanto à precisão, adequação e suficiência das informações nem ausência de defeitos, e não assume nenhuma responsabilidade relacionada a qualquer utilização das mesmas. Qualquer usuário deste produto tem a responsabilidade de determinar a adequação dos produtos da Clariant à sua aplicação específica.<br />
<br />
* Nada que conste nestas informações afeta as Condições e termos gerais de vendas da Clariant, salvo se acordado, de outra forma, por escrito. Devem ser observados quaisquer direitos de propriedade intelectual/industrial existentes. Devido a possíveis alterações em nossos produtos e em leis e regulamentos aplicáveis nacionais e internacionais, a condição de nossos produtos pode se alterar. São disponibilizadas, mediante solicitação, Fichas de Informações de Segurança de Produtos Químicos contendo precauções de segurança, as quais devem ser observadas na manipulação ou no armazenamento dos produtos Clariant, que serão providenciadas em conformidade com a lei vigente. Deve-se obter e analisar as informações aplicáveis da Ficha de Informações de Segurança de Produtos Químicos antes de manipular qualquer desses produtos. Para mais informações, entre em contato com a Clariant.<br />
<br />
* Para vendas a clientes localizados nos Estados Unidos e no Canadá, aplica-se também a seguinte disposição: NENHUMA GARANTIA EXPRESSA OU IMPLÍCITA É FORNECIDA SOBRE A COMERCIALIZAÇÃO, ADEQUAÇÃO E APTIDÃO PARA UM PROPÓSITO PARTICULAR OU DIFERENTE DE QUALQUER PRODUTO OU SERVIÇO.<br />
<br />
© Marca registrada da Clariant registrada em muitos países.<br />
® 2019 Clariant International Ltd 

Você está prestes a sair do domínio da Clariant

O link que você acessou levará você para fora do site da Clariant em aproximadamente 10 segundos. Caso deseje interromper esta operação, pressione “Cancelar”.

Solicitação à Clariant

Insira suas informações de contato para que possamos processar sua solicitação. Obrigado por seu interesse.

Dr. Christian Librera
Dr. Christian Librera
Contact Person